As a recognized life science and digital health thought-leader, Wain is a frequent speaker at programs addressing industry issues, including the International CES Digital Health Summit, USC’s Body Computing Conference, Impact Forum and the Samsung: Health + Tech Conference. Wain has also served as the Chair of the BIO Digital Health Forum at the BIO International Convention from 2014 – 2018.
Wainwright is immediate past Chairman of the Sanford-Burnham Institute for Medical Research, a leading independent biomedical research organization. He is a founding director of the Corporate Directors Forum and BIOCOM, and a member of BIOCOM’s Executive Committee. He serves on the faculty of the Eureka Institute for Translational Medicine and on the Board of the Critical Path Institute, an organization created in part by the FDA, dedicated to improving the regulatory path for innovative therapies.
Wainwright is a co-founder of seven companies, two of which are public.